Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Abstract Background Nocturia is a common urinary symptom of multiple sclerosis (MS) which can affect quality of life (QoL) adversely. Melatonin is a hormone known to regulate circadian rhythm and reduce smooth muscle activity such as in the bladder. There is limited evidence supporting use of melato...

Full description

Bibliographic Details
Main Authors: Marcus J. Drake, Luke Canham, Nikki Cotterill, Debbie Delgado, Jenny Homewood, Kirsty Inglis, Lyndsey Johnson, Mary C. Kisanga, Denise Owen, Paul White, David Cottrell
Format: Article
Language:English
Published: BMC 2018-08-01
Series:BMC Neurology
Subjects:
Nocturia
Multiple sclerosis
Melatonin
Antidiuretic
Antimuscarinic
LUTS
Online Access:http://link.springer.com/article/10.1186/s12883-018-1114-4

Internet

http://link.springer.com/article/10.1186/s12883-018-1114-4

Similar Items